Masayoshi Son is Selling These 4 Stocks in 2022

Page 1 of 3

In this article, we discuss the 4 stocks Masayoshi Son is selling in 2022. If you want to read our detailed analysis of Son’s stock picks and hedge fund history, go directly to Masayoshi Son is Selling These 9 Stocks in 2022.

4. Sana Biotechnology, Inc. (NASDAQ:SANA)

Number of Hedge Fund Holders: 11

Change in Stake: -100%

Masayoshi Son completely sold off his stake in Sana Biotechnology, Inc. (NASDAQ:SANA) during the first quarter. The Seattle-based firm develops engineered cells to be used as therapies for various diseases. It is developing the technology required to create cells that can replaced diseased cells in a body, and also repair cells that are impaired/damaged.

A study of the 912 hedge funds tracked by Insider Monkey at the end of March showed that 11 hedge funds held positions in Sana Biotechnology, Inc. (NASDAQ:SANA) with a collective price tag of $32.5 million. The same number of hedge funds reported owning stakes in the company a quarter ago as well.

Woodline Partners was the biggest shareholder of Sana Biotechnology, Inc. (NASDAQ:SANA) in Q1 2022, with a position worth $12.8 million. Famed quant investor Jim Simons’ Renaissance Technologies also held a $6.9 million stake in the company.


Page 1 of 3